4.3 Article

Efficacy of Trial Fitting and Software Fitting for Orthokeratology Lens: One-Year Follow-Up Study

Journal

EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE
Volume 44, Issue 5, Pages 339-343

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ICL.0000000000000539

Keywords

Orthokeratology lens; Trial fitting and software fitting; Efficacy

Categories

Funding

  1. National Nature Science Foundation of China [81570834]
  2. Science Committee Nature Science Foundation of Tianjin [17ZXHLSY00070]

Ask authors/readers for more resources

Objective: To observe and compare the clinical efficacy of 1-year trial fitting and software fitting orthokeratology lenses. Methods: One hundred myopes who received vision correction with the use of orthokeratology lenses form July 2016 to September 2017 were included in this study. Subjects were assigned randomly into the two groups: the trial fitting group (group A) and the software fitting group (group B). For the right eye of each subject, measurements, such as uncorrected visual acuity (UCVA, logarithm of minimal angle of resolution), refractive error, corneal topography, ocular health status, and the fitting situation, were obtained at baseline, 1 week, 1 month, 3 months, 6 months, and 12 months after lens wear. Axial length and corneal endothelium cells (CECs) were also measured at baseline and 12 months after wearing the lens. Results: Compared with the baseline, the spherical equivalent refraction, UCVA, and central corneal curvature changed significantly after orthokeratology (OK) lens wear (all P<0.05). Between groups A and B, the parameters aforementioned were insignificant at each time point (all P>0.05). Axial length and CECs showed no significant changes during the first year of OK treatment (all P>0.05). Rate of corneal staining between two groups revealed no difference during 1-year visit (P<0.05). Conclusion: Both the trial lens fitting and software fitting approaches were effective in temporarily reducing myopia, providing good UCVA and delaying the elongation of axial length for moderate and high myopic adolescents. Both the two approaches can be combined in OK lens fitting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Ophthalmology

Influence of Corneal Topographic Parameters in the Decentration of Orthokeratology

Tianpu Gu, Boteng Gong, Daqian Lu, Weiping Lin, Na Li, Qing He, Ruihua Wei

EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE (2019)

Article Ophthalmology

Meibomian Gland Dropout, not Distortion, Can Distinguish Dry Eyes from Normal Eyes in Contact Lens Wearers

Tianpu Gu, Bei Du, Hua Bi, Lu Zhou, Guihua Liu, Nan Jin, Zhuzhu Liu, Bin Zhang, Ruihua Wei

CURRENT EYE RESEARCH (2020)

Article Ophthalmology

Evaluation of tear film and the morphological changes of meibomian glands in young Asian soft contact lens wearers and non-wearers

Tianpu Gu, Lu Zhao, Zhuzhu Liu, Shaozhen Zhao, Hong Nian, Ruihua Wei

BMC OPHTHALMOLOGY (2020)

Article Ophthalmology

A prospective study of serum metabolomic and lipidomic changes in myopic children and adolescents

Bei Du, Nan Jin, Xiurui Zhu, Daqian Lu, Chengcheng Jin, Zhen Li, Chunle Han, Yani Zhang, Donghai Lai, Kang Liu, Ruihua Wei

EXPERIMENTAL EYE RESEARCH (2020)

Article Ophthalmology

Comparison of A-Scan ultrasonography and the Lenstar optical biometer in Guinea pig eyes

Qiong Wang, Xiaowen Ji, Daqian Lu, Ying Zhu, Amy Whelchel, Jingyi Wang, Hongmei Zhang, Lijie Dong, Ruihua Wei

Summary: The Lenstar optical biometer showed better repeatability and provided smaller measurements for Delta L, VCD, and ASD compared to A-scan ultrasonography. There was a high correlation between the two devices in measuring Delta AL. While the devices did not agree in absolute measurements, the Lenstar can still be considered as an option in measuring the difference in AL between eyes in a guinea pig myopia model.

EXPERIMENTAL EYE RESEARCH (2021)

Article Pharmacology & Pharmacy

Alteration of EIF2 Signaling, Glycolysis, and Dopamine Secretion in Form-Deprived Myopia in Response to 1% Atropine Treatment: Evidence From Interactive iTRAQ-MS and SWATH-MS Proteomics Using a Guinea Pig Model

Ying Zhu, Jing Fang Bian, Da Qian Lu, Chi Ho To, Carly Siu-Yin Lam, King Kit Li, Feng Juan Yu, Bo Teng Gong, Qiong Wang, Xiao Wen Ji, Hong Mei Zhang, Hong Nian, Thomas Chuen Lam, Rui Hua Wei

Summary: This study investigated the retinal protein changes in a form-deprived myopic guinea pig model treated with 1% atropine gel. The results revealed the involvement of retinal EIF2 signaling, glycolysis, and dopamine secretion pathways in atropine treatment of myopia. The study utilized next-generation proteomics to provide molecular evidence for the mechanism of atropine's effect on myopia progression.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Retinal Proteomic Analysis in a Mouse Model of Endotoxin-Induced Uveitis Using Data-Independent Acquisition-Based Mass Spectrometry

Jing Zhang, Jiangmei Wu, Daqian Lu, Chi-Ho To, Thomas Chuen Lam, Bin Lin

Summary: This study investigated the changes in the retinal proteomic profile in the EIU mouse model using mass spectrometry analysis. The study identified differentially expressed proteins related to uveitis and acute retinal inflammation, and identified important pathways associated with these conditions. These findings provide potential candidates for exploring the mechanism and novel therapeutic targets for uveitis and other retinal inflammatory diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

Combined retinal proteome datasets in response to atropine treatment using iTRAQ and SWATH-MS based proteomics approaches in guinea pig myopia model

Ying Zhu, Jingfang Bian, Daqian Lu, Qiong Wang, Boteng Gong, King-Kit Li, Fengjuan Yu, Jimmy Ka-Wai Cheung, Xiaowen Ji, Hongmei Zhang, Bei Du, Hong Nian, Chi-ho To, Ruihua Wei, Thomas Chuen Lam

DATA IN BRIEF (2020)

No Data Available